We randomized @,@ patients with type @ diabetes mellitus ( T@DM ) and stage @ chronic kidney disease ( CKD ) ( estimated glomerular filtration rate @ to < @ mL min ( -@ ) @ m ( -@ ) ) to once-daily bardoxolone methyl ( @ mg ) or placebo .